Brief: Alembic Pharmaceuticals Gets US FDA Tentative Approval For Bosutinib Tablets 100 Mg, 500 Mg
01/07/2024 05:36
July 1 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* ALEMBIC PHARMACEUTICALS LTD - RECEIVED USFDA TENTATIVE
APPROVAL
FOR BOSUTINIB TABLETS 100MG AND 500 MG
Source text for Eikon: ID:nBSEVqBGb
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand